Name: Green Orange Blue Creative Healthcare Facility Presentation
Uploaded: 2024-03-18
Duration: 4 min 17 s
Description: IDOSE TR Role play between medical rep and doctor.

[Audio] IDOSE TR Role play between medical rep and doctor. 

Scene 1

[Audio] DOCTOR MEDICAL REP GOOD MORNING, DR. SMITH. I HOPE YOU'RE DOING WELL TODAY. GOOD MORNING. YES, I'M DOING FINE, THANK YOU. HOW CAN I HELP YOU?. 

Scene 2

GOOD MORNING, DR.  SMITH. I HOPE YOU'RE  DOING WELL TODAY.

GOOD MORNING.  YES, I'M DOING FINE,  THANK YOU. HOW  CAN I HELP YOU?

[Audio] Doctor Medical rep I've heard a bit about iDose TR. I'm here to discuss a new treatment option for glaucoma patients that I believe could greatly benefit your practice. It's called iDose TR, manufactured by Glaukos Corporation, and it's been making waves in the ophthalmology community.. 

Scene 3

I'm here to discuss a new treatment option for glaucoma patients that I believe could greatly benefit your practice. It's called iDose TR, manufactured by Glaukos Corporation, and it's been making waves in the ophthalmology community.

[Audio] Medical rep Doctor iDose TR is a sustained-release implant that delivers a consistent dose of medication directly into the eye over an extended period of time. It offers a unique advantage by providing a continuous therapeutic effect, reducing the need for frequent administration of eye drops. Plus, it comes in different doses, allowing for personalized treatment plans tailored to each patient's specific needs. What makes it stand out from other treatments for glaucoma?. 

Scene 4

iDose TR is a sustained-release implant that delivers a consistent dose of medication directly into the eye over an extended period of time. It offers a unique advantage by providing a continuous therapeutic effect, reducing the need for frequent administration of eye drops. Plus, it comes in different doses, allowing for personalized treatment plans tailored to each patient's specific needs.

What makes it stand out from other treatments for glaucoma?

[Audio] Medical rep Doctor There have been several clinical trials evaluating the effectiveness of iDose TR, all conducted by Glaukos Corporation. One study published in the Journal of Glaucoma compared iDose TR to topical eye drops and found that patients receiving iDose TR had significantly lower IOP levels and required fewer additional medications. to control their glaucoma. Additionally, another study published in the American Journal of Ophthalmology demonstrated that iDose TR had a favorable safety profile with minimal adverse events reported. That sounds promising. What evidence supports its efficacy and safety?. 

Scene 5

There have been several clinical trials evaluating the effectiveness of iDose TR, all conducted by Glaukos Corporation. One study published in the Journal of Glaucoma compared iDose TR to topical eye drops and found that patients receiving iDose TR had significantly lower IOP levels and required fewer additional medications. to control their glaucoma. Additionally, another study published in the American Journal of Ophthalmology demonstrated that iDose TR had a favorable safety profile with minimal adverse events reported.

That sounds promising. What evidence supports its efficacy and safety?

[Audio] Doctor Impressive. And what about the cost? MEDICAL rep While the initial cost of iDose TR may be higher than traditional eye drop therapies, it's essential to consider the long-term benefits and potential cost savings. With iDose TR's sustained-release mechanism, patients may require fewer additional medications and fewer office visits for medication adjustments over time. Additionally, many insurance plans cover iDose TR, so it's worth checking with individual insurance providers to understand coverage options.. 

Scene 6

While the initial cost of iDose TR may be higher than traditional eye drop therapies, it's essential to consider the long-term benefits and potential cost savings. With iDose TR's sustained-release mechanism, patients may require fewer additional medications and fewer office visits for medication adjustments over time. Additionally, many insurance plans cover iDose TR, so it's worth checking with individual insurance providers to understand coverage options.

[Audio] Medical rep Doctor What about potential side effects? While iDose TR has demonstrated a favorable safety profile in clinical trials, it's essential to be aware of potential side effects. Common side effects may include mild discomfort or irritation at the implantation site, transient changes in vision, and rare instances of infection or inflammation. However, serious adverse events are rare with iDose TR. Patients should be informed about these potential side effects and instructed to contact their healthcare provider if they experience any concerning symptoms.. 

Scene 7

While iDose TR has demonstrated a favorable safety profile in clinical trials, it's essential to be aware of potential side effects. Common side effects may include mild discomfort or irritation at the implantation site, transient changes in vision, and rare instances of infection or inflammation. However, serious adverse events are rare with iDose TR. Patients should be informed about these potential side effects and instructed to contact their healthcare provider if they experience any concerning symptoms.

[Audio] Thank you for providing this comprehensive overview. I'm definitely interested in incorporating iDose TR into my treatment options for glaucoma patients. Can you tell me more about the different doses available and how they fit into the treatment plan? Certainly, iDose TR comes in different doses, allowing for personalized treatment plans based on each patient's specific needs and severity of glaucoma. The implant delivers a consistent dose of medication over a predetermined period, typically ranging from several months to a year. This allows for a convenient and effective treatment option that can be tailored to each patient's individual response and disease progression.. 

Scene 8

Thank you for providing this comprehensive overview. I'm definitely interested in incorporating iDose TR into my treatment options for glaucoma patients. Can you tell me more about the different doses available and how they fit into the treatment plan?

Certainly, iDose TR comes in different doses, allowing for personalized treatment plans based on each patient's specific needs and severity of glaucoma. The implant delivers a consistent dose of medication over a predetermined period, typically ranging from several months to a year. This allows for a convenient and effective treatment option that can be tailored to each patient's individual response and disease progression.

[Audio] Doctor Medical rep Absolutely, I'll provide you with all the necessary resources and support. Thank you for considering iDose TR as a valuable addition to your practice. That makes sense. Thank you for clarifying. Please provide me with more information, including dosing guidelines and educational materials, so I can further explore incorporating iDose TR into my practice.. 

Scene 9

That makes sense. Thank you for clarifying. Please provide me with more information, including dosing guidelines and educational materials, so I can further explore incorporating iDose TR into my practice.

Absolutely, I'll provide you with all the necessary resources and support. Thank you for considering iDose TR as a valuable addition to your practice.

Green Orange Blue Creative Healthcare Facility Presentation

Scene 0

IDOSE TR
 Role play between medical rep and doctor

avatar

Doctor
 Medical Rep
 Good Morning
 Dr.  Smith. I Hope You're  Doing Well Today.
 Good Morning.  Yes
 I'm Doing Fine
  Thank You. How  Can I Help You?

Doctor 
 Medical rep 
  I've heard a bit about iDose TR.

  I'm here to discuss a new treatment option for glaucoma patients that I believe could greatly benefit your practice. It's called iDose TR
 manufactured by Glaukos Corporation
 and it's been making waves in the ophthalmology community.

Medical rep 
 Doctor 
 iDose TR is a sustained-release implant that delivers a consistent dose of medication directly into the eye over an extended period of time. It offers a unique advantage by providing a continuous therapeutic effect
 reducing the need for frequent administration of eye drops. Plus
 it comes in different doses
 allowing for personalized treatment plans tailored to each patient's specific needs.

  What makes it stand out from other treatments for glaucoma?

Medical rep 
 Doctor 
 There have been several clinical trials evaluating the effectiveness of iDose TR
 all conducted by Glaukos Corporation. One study published in the Journal of Glaucoma compared iDose TR to topical eye drops and found that patients receiving iDose TR had significantly lower I-O-P levels and required fewer additional medications. to control their glaucoma. Additionally
 another study published in the American Journal of Ophthalmology demonstrated that iDose TR had a favorable safety profile with minimal adverse events reported.

 That sounds promising. What evidence supports its efficacy and safety?

Doctor 
 Impressive. And what about the cost?

 medical rep 

 While the initial cost of iDose TR may be higher than traditional eye drop therapies
 it's essential to consider the long-term benefits and potential cost savings. With iDose TR's sustained-release mechanism
 patients may require fewer additional medications and fewer office visits for medication adjustments over time. Additionally
 many insurance plans cover iDose TR
 so it's worth checking with individual insurance providers to understand coverage options.

Medical rep 
 Doctor 
 What about potential side effects?

 While iDose TR has demonstrated a favorable safety profile in clinical trials
 it's essential to be aware of potential side effects. Common side effects may include mild discomfort or irritation at the implantation site
 transient changes in vision
 and rare instances of infection or inflammation. However
 serious adverse events are rare with iDose TR. Patients should be informed about these potential side effects and instructed to contact their healthcare provider if they experience any concerning symptoms.

Thank you for providing this comprehensive overview. I'm definitely interested in incorporating iDose TR into my treatment options for glaucoma patients. Can you tell me more about the different doses available and how they fit into the treatment plan?

 Certainly
 iDose TR comes in different doses
 allowing for personalized treatment plans based on each patient's specific needs and severity of glaucoma. The implant delivers a consistent dose of medication over a predetermined period
 typically ranging from several months to a year. This allows for a convenient and effective treatment option that can be tailored to each patient's individual response and disease progression.

Doctor 
 Medical rep 
 Absolutely
 I'll provide you with all the necessary resources and support. Thank you for considering iDose TR as a valuable addition to your practice.

 That makes sense. Thank you for clarifying. Please provide me with more information
 including dosing guidelines and educational materials
 so I can further explore incorporating iDose TR into my practice.